Thermo Fisher Scientific Inc (NYSE:TMO) insider Daniel P. Shine sold 2,026 shares of the company’s stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $180.97, for a total value of $366,645.22. Following the sale, the insider now owns 20,682 shares of the company’s stock, valued at $3,742,821.54. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at 186.00 on Friday. The firm has a market cap of $72.56 billion, a PE ratio of 32.40 and a beta of 1.04. Thermo Fisher Scientific Inc has a 52 week low of $139.07 and a 52 week high of $188.76. The stock has a 50 day moving average price of $177.39 and a 200 day moving average price of $168.43.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.03. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The company had revenue of $5 billion during the quarter, compared to analyst estimates of $4.92 billion. During the same quarter in the previous year, the company posted $2.03 EPS. Thermo Fisher Scientific’s revenue for the quarter was up 10.2% on a year-over-year basis. Equities analysts expect that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.45%.

COPYRIGHT VIOLATION NOTICE: “Daniel P. Shine Sells 2,026 Shares of Thermo Fisher Scientific Inc (TMO) Stock” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://www.watchlistnews.com/daniel-p-shine-sells-2026-shares-of-thermo-fisher-scientific-inc-tmo-stock/1537642.html.

Several large investors have recently added to or reduced their stakes in TMO. Vanguard Group Inc. raised its stake in Thermo Fisher Scientific by 2.4% in the second quarter. Vanguard Group Inc. now owns 26,600,394 shares of the medical research company’s stock worth $4,640,970,000 after buying an additional 629,093 shares during the period. BlackRock Inc. increased its position in shares of Thermo Fisher Scientific by 1.6% in the second quarter. BlackRock Inc. now owns 23,355,469 shares of the medical research company’s stock worth $4,074,828,000 after buying an additional 366,584 shares in the last quarter. Capital Research Global Investors increased its position in shares of Thermo Fisher Scientific by 29.8% in the second quarter. Capital Research Global Investors now owns 17,304,897 shares of the medical research company’s stock worth $3,019,185,000 after buying an additional 3,973,136 shares in the last quarter. State Street Corp increased its position in shares of Thermo Fisher Scientific by 1.0% in the first quarter. State Street Corp now owns 16,085,954 shares of the medical research company’s stock worth $2,470,802,000 after buying an additional 164,367 shares in the last quarter. Finally, Capital World Investors increased its position in shares of Thermo Fisher Scientific by 6.1% in the second quarter. Capital World Investors now owns 11,759,734 shares of the medical research company’s stock worth $2,051,721,000 after buying an additional 671,637 shares in the last quarter. 83.52% of the stock is owned by institutional investors.

Several equities analysts have commented on the company. Cowen and Company reiterated a “buy” rating and issued a $200.00 target price on shares of Thermo Fisher Scientific in a research report on Friday. Bank of America Corporation reiterated a “buy” rating and issued a $210.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Friday, July 21st. Barclays PLC reiterated an “overweight” rating and issued a $200.00 target price (up from $190.00) on shares of Thermo Fisher Scientific in a research report on Monday, July 17th. Cleveland Research upgraded Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research report on Thursday, July 20th. Finally, Wells Fargo & Company reiterated an “outperform” rating and issued a $200.00 target price (up from $195.00) on shares of Thermo Fisher Scientific in a research report on Thursday, July 13th. One equities research analyst has rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $189.50.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Insider Buying and Selling by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.